Pintas & Mullins Law Firm

Blog Posts in November, 2009

  • Recall of Dangerous Drop-Side Cribs

    On November 23, 2009, the Consumer Product Safety Commission recalled 2.1 million Stork Craft drop-side cribs. The recall occurred due to the growing concern about a defect in the crib’s drop-slide feature, which allows the crib’s gate to slide up and down. This defect can lead to the plastic hardware of the drop-side breaking, which may cause one of the corners of the crib to detach. Due to ...
    Continue Reading
  • Label Changes Mandated for Pain Pumps Due to Dangers of Permanent Cartilage Damage

    A recent report from the Wall Street Journal stated that the FDA is seeking to change labels on pain pumps that deliver pain medication to patients after surgery. Pain pumps are small plastic tubes that deliver and regulate pain medication, usually for a couple of days. The proposed label changes come in the wake of many reports of irreversible cartilage damage from patients who had the medication ...
    Continue Reading
  • FDA Warnings against Simultaneous Use of Plavix and Prilosec or Nexium

    Millions of Americans take the blood thinner Plavix to reduce their risk of blood clots, which may lead to heart attack or stroke. Since Plavix can lead to an upset stomach, doctors often prescribe Prilosec and Nexium to treat this symptom. However, the FDA recently issued warnings that these medications may decrease the anti-clotting benefits by Plavix by almost half. This can be very dangerous, ...
    Continue Reading
  • Recall of 2010 Volvo XC60 Due to Seatbelt Defects

    Volvo recently announced that it was recalling over 9,000 of its 2010 XC60s, because of potential seat belt defects. Last month, the Insurance Institute of Highway Safety conducted a side-impact test to determine which cars would be included in its "Top Safety Pick" awards. Unexpectedly, during the crash test, the driver's seat belt in the Volvo XC60 came undone. A Volvo spokesman reported the ...
    Continue Reading
  • Chicago Psychiatrist has Troubling Record with Clozapine

    The Chicago Tribune recently reported that Dr. Michael Reinstein, a doctor who frequently gives psychiatric care in Chicago-area nursing homes and mental health facilities, has developed a troubling record. This record involves providing care with an extremely risky drug: Clozapine. Clozapine is a very powerful drug that carries five FDA black box warnings, the strongest warnings the FDA can ...
    Continue Reading
  • Accutane and Increased Risk of Inflammatory Bowel Disease

    In June of this year, Roche Holding quietly pulled the drug Accutane from the market. Accutane is prescribed to treat moderate to severe cases of acne. The drug has had an extensive history of leading to adverse effects since its approval in 1982, such as suicidal behavior and birth defects. The removal of the drug from the market came in the face of increasing proof that Accutane leads to another ...
    Continue Reading
  • Federal Investigation into Marketing Practices of Depakote

    The Chicago Tribune recently reported that Abbott Laboratories is under investigation for their sale and marketing practices of Depakote. Depakote is prescribed primarily to treat bipolar disorder. In certain cases, it is also used to treat major depressive disorder, epilepsy, chronic pain associated with neuropathy, and migraine headaches. The federal probe was initiated to find out if Abbott ...
    Continue Reading
  • Pending Mass Tort Status for Yaz and Yasmin Claims

    The New Jersey Judiciary is currently considering a request for mass tort status for an increasing number of lawsuits against the popular birth control drugs Yaz, Yasmin and Ocella. The lawsuits allege that use of these contraceptives results in serious health effects, such as stroke and heart attacks. The New Jersey Law Journal reports that this consideration for mass tort status is due to a ...
    Continue Reading
  • Zicam Shareholder Lawsuit

    On Thursday of last week, a federal appeals court unanimously voted to reinstate a shareholder lawsuit against Matrixx Initiatives, the makers of the popular cold remedy Zicam. The lawsuit claims that the shareholders of the company did not disclose information that the drug was potentially harmful to the public and instead issued incorrect and misleading statements. Judge Tashima, a part of the ...
    Continue Reading
  • Taking Aranesp Increases Your Risk of Suffering a Stroke

    A new study published last week pointed to an increased risk of stroke for patients taking the medication Aranesp . Aranesp is part of a class of drugs known as erythropoiesis-stimulating agents (ESAs), which stimulate the body to produce more red blood cells. ESAs are primarily used to treat anemia in patients with chronic kidney failure, cancer patients who became anemic through chemotherapy, ...
    Continue Reading
Page 1 of 1
Free Consultation
  • Please enter your first name.
  • Please enter your last name.
  • Please enter your email.
    This isn't a valid email address.
  • Please enter your phone number.
    This isn't a valid phone number.
  • Please make a selection.
  • Please make a selection.
  • Please enter your message.